Impact of beta-blockers on mortality and cardiovascular disease outcomes in patients with obstructive sleep apnoea: a population-based cohort study in target trial emulation frameworkResearch in context
Summary: Background: There is no real-world evidence regarding the association between beta-blocker use and mortality or cardiovascular outcomes in patients with obstructive sleep apnoea (OSA). We aimed to investigate the impact of beta-blocker use on all-cause mortality and cardiovascular diseases...
Main Authors: | Anthony Chen, Chengsheng Ju, Isla S. Mackenzie, Thomas M. MacDonald, Allan D. Struthers, Li Wei, Kenneth K.C. Man |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2023-10-01
|
Series: | The Lancet Regional Health. Europe |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2666776223001345 |
Similar Items
-
Repurposing beta-blockers for combinatory cancer treatment: effects on conventional and immune therapies
by: Rachel Massalee, et al.
Published: (2024-01-01) -
Lower In‐Hospital Mortality With Beta‐Blocker Use at Admission in Patients With Acute Decompensated Heart Failure
by: Yodo Tamaki, et al.
Published: (2021-07-01) -
Effect of beta-blockers on exacerbation rate and lung function in chronic obstructive pulmonary disease (COPD)
by: Sean Duffy, et al.
Published: (2017-06-01) -
Cardioselective versus Non-Cardioselective Beta-Blockers and Outcomes in Patients with Atrial Fibrillation and Chronic Obstructive Pulmonary Disease
by: Dimitra Vlachopoulou, et al.
Published: (2023-04-01) -
Do beta-blockers reduce negative intrusive thoughts and anxiety in cancer survivors? – An emulated trial
by: Carolina Ehrencrona, et al.
Published: (2024-04-01)